Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer
Clinical trial NCT06088030 · RECRUITING
Trial details
- NCT number
- NCT06088030
- Sponsor
- Yang Li
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-13
- Primary completion
- 2031-12-14
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.